title: Physicochemical properties of macrogol ointment and emulsion ointment blend developed for regulation of water absorption.
abstract: Pressure ulcers can form with excess pressure and shearing stress on skin tissue. Because pressure ulcer is often accompanies by exudates, selection of appropriate topical emulsion ointment is difficult. Blended ointments consisting of emulsion base and water-soluble base are clinically used for adjustment of wound moist environment. Because regulating the amount of wound exudates can enhance treatment efficacy, two new blended ointments were developed. LY-SL blended ointment consisted of lysozyme hydrochloride water-in-oil (w/o) emulsion (LY-cream) and sulfadiazine macrogol (polyethylene glycol) ointment (SL-pasta). TR-SL blended ointment consisted of tretinoin tocoferil oil-in-water (o/w) emulsion (TR-cream) and SL-pasta (TR-SL). LY-SL and TR-SL were applied to Franz diffusion cell with cellulose membranes for the evaluation of water absorption characteristics at 32 °C. Water absorption rate constants (mg/cm(2)/min(0.5)) were 12.5, 16.3 and 34.6 for LY-cream, TR-cream and SL-pasta, respectively. Water absorption rate constants for LY-SL and TR-SL (SL-pasta 70%) exhibited intermediate values of 21.2 and 27.2, as compared to each ointment alone, respectively. Because amount of water absorbed was linearly related to square root of time, it was suggested that water-absorbable macrogol was surrounded by oily ingredients forming matrix structure. This diffusion-limited structure may regulate water absorption capacity. This is the first report of physicochemical properties of macrogol ointment and emulsion ointment blend developed for regulation of water absorption. The blended ointment can properly regulate amount of exudates in wounds and may be useful for treatment of pressure ulcers.
authors.affiliation: Department of Pharmacy, College of Pharmacy, Kinjogakuin University, Nagoya, Japan.
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Noda
authors.forename: Kazuya
authors.initials: K
authors.lastname: Watanabe
authors.forename: Akimasa
authors.initials: A
authors.lastname: Sanagawa
authors.forename: Yu
authors.initials: Y
authors.lastname: Sobajima
authors.forename: Satoshi
authors.initials: S
authors.lastname: Fujii
mesh_terms: D002482:Cellulose / Q000737:chemistry; D015194:Diffusion Chambers, Culture; D004337:Drug Carriers / Q000737:chemistry; D004338:Drug Combinations; D004655:Emulsions; D005122:Exudates and Transudates / Q000378:metabolism; D008567:Membranes, Artificial; D009113:Muramidase / Q000008:administration & dosage*; D009824:Ointments; D011092:Polyethylene Glycols / Q000737:chemistry*; D003668:Pressure Ulcer / Q000188:drug therapy / Q000473:pathology; D012995:Solubility; D013411:Sulfadiazine / Q000008:administration & dosage*; D013997:Time Factors; D014212:Tretinoin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D014810:Vitamin E / Q000008:administration & dosage / Q000031:analogs & derivatives*; D014867:Water / Q000378:metabolism
chemical_list: D004337:Drug Carriers; D004338:Drug Combinations; D004655:Emulsions; D008567:Membranes, Artificial; D009824:Ointments; D014867:Water; D013411:Sulfadiazine; D014810:Vitamin E; D011092:Polyethylene Glycols; D014212:Tretinoin; D002482:Cellulose; C089853:tocoretinate; D009113:Muramidase